Quality-of-life testing may predict malignancy and survival in patients with pancreatic disease
Tuesday, May 4, 2010 - 09:50
in Health & Medicine
Quality-of-life measures used routinely to assess treatment outcomes for patients with pancreatic disease may be used to predict both malignancy and survival for those patients, according to a study by Henry Ford Hospital...